NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/14/2026
Back to search
Official data from USPTO
MI TUMOR SEEK HYBRID
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MI TUMOR SEEK HYBRID
ST13
US500000098581653Class
44
Filing
98581653
Registration
8340463
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
07/14/2026
Trademark type
Word
Nice classes
44
Filing date
06/03/2024
Registration date
07/14/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/14/2026
Last transaction
07/14/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/27/2024
First use in commerce
05/27/2024
Drawing code
4
Owner type
03
Owner location
Irving, TX, US
Examiner
ADEYIGA, ADETAYO JANET
Law office
L90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Caris MPI, Inc.
Representatives
Anne Fleeson Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Genomic and molecular medical testing services for diagnostic or treatment purposes in the field of cancer; diagnostic servicesmedical diagnostic testing for cancer and other diseases and disorders; providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical data and information to healthcare professionals
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/14/2026
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/26/2026
PUBO
PUBLISHED FOR OPPOSITION
05/26/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/20/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/24/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
04/24/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/24/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
04/24/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/24/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/27/2026
GNFR
FINAL REFUSAL E-MAILED
02/27/2026
CNFR
FINAL REFUSAL WRITTEN
02/27/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/04/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/10/2024
GNRT
NON-FINAL ACTION E-MAILED
12/10/2024
CNRT
NON-FINAL ACTION WRITTEN
12/10/2024
DOCK
ASSIGNED TO EXAMINER
09/23/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/14/2024
NWAP
NEW APPLICATION ENTERED
06/03/2024
Continuous trademark protection
Get notified about every new filing that threatens MI TUMOR SEEK HYBRID or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.